All news articles for September 2018

(Image: Getty/Phototechno)

Hired and Retired: Big pharma to biotech trend continues

By Ben Hargreaves

As the stream of executives flowing from large pharma companies to smaller biotechs builds into a torrent, another month has passed with a number of significant switches. Notably, two former Genentech employees, responsible for work on some of its bestselling...

(Image: Getty/Filipfoto)

US FDA eases Teva headache with Ajovy approval

By Flora Southey

Regulatory setbacks at Teva’s CMO facility in Korea have not halted the regulatory progression of preventive migraine treatment Ajovy, which has received US FDA approval.

(Image: Getty/Ronniechua)

How the US-Mexico trade deal could impact the biologics market

By Ben Hargreaves

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lione’s biopharma practice group, the provisional detail revealed from the US administration’s proposed trade deal with Mexico, and its potential impact on the...

(Image: Getty/bohemia8)

NORDIC LIFE SCIENCE DAYS

Missed #NSLDays in Sweden? Live dispatches from Stockholm

By Flora Southey

As Nordic Life Science Days draws to a close for 2018, so too do the conference ‘super sessions’, covering patient engagement, precision medicine, drug delivery and immune-oncology.

Biopharma-Reporter is on the ground, bringing you the...